Literature DB >> 28268832

Automated ongoing data validation and quality control of multi-institutional studies.

Lara J Kanbar, Wissam Shalish, Doina Precup, Karen Brown, Guilherme M Sant'Anna, Robert E Kearney.   

Abstract

This paper addresses the problem of ensuring the validity and quality of data in ongoing multi-disciplinary studies where data acquisition spans several geographical sites. It describes an automated validation and quality control procedure that requires no user supervision and monitors data acquired from different locations before analysis. The procedure is illustrated for the Automated Prediction of Extubation readiness (APEX) project in preterm infants, where acquisition of clinical and cardiorespiratory data occurs at 6 sites using different equipment and personnel. We have identified more than 40 problems with clinical information and 25 possible problems with the cardiorespiratory signals. Our validation and quality control procedure identifies these problems in an ongoing manner so that they can be timely addressed and corrected throughout this long-term collaborative study.

Entities:  

Mesh:

Year:  2016        PMID: 28268832     DOI: 10.1109/EMBC.2016.7591239

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  2 in total

1.  Patterns of reintubation in extremely preterm infants: a longitudinal cohort study.

Authors:  Wissam Shalish; Lara Kanbar; Martin Keszler; Sanjay Chawla; Lajos Kovacs; Smita Rao; Bogdan A Panaitescu; Alyse Laliberte; Doina Precup; Karen Brown; Robert E Kearney; Guilherme M Sant'Anna
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

2.  Prediction of Extubation readiness in extremely preterm infants by the automated analysis of cardiorespiratory behavior: study protocol.

Authors:  Wissam Shalish; Lara J Kanbar; Smita Rao; Carlos A Robles-Rubio; Lajos Kovacs; Sanjay Chawla; Martin Keszler; Doina Precup; Karen Brown; Robert E Kearney; Guilherme M Sant'Anna
Journal:  BMC Pediatr       Date:  2017-07-17       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.